Codexis has agreed to manufacture 50 grams of siRNA using its proprietary ECO Synthesis manufacturing platform to support ...

Fujifilm Biotechnologies is unveiling a precision purification tool, ShunzymeX, that simplifies downstream processing for ...

Rovadicitinib is approved in China for myelofibrosis and is in late-stage development for chronic graft-versus-host disease.

Moderna has entered into a settlement agreement resolving all worldwide Arbutus Biopharma Corporation/Genevant Sciences GmbH ...

Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting KIT-driven cancers.

Purchases a GEA Pharma-SD type PSD-4 solvent-capable spray dryer designed to produce commercial batches up to 500 kg.

Duvakitug is currently in phase 3 trials for ulcerative colitis and Crohn’s disease.

Antheia has expanded the scope of its second project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium, securing an additional $9 million.

Will house process development and analytical services for advanced peptide API production from development through commercialization.

CellCarta, a global CRO laboratory to the biopharmaceutical industry, has appointed Ehab A. El-Gabry, MD, as Chief Medical ...

ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

Latigo Biotherapeutics is appointing Neha Krishnamohan as both Chief Financial Officer (CFO) and Chief Business Officer (CBO) ...